Literature DB >> 20723007

Aloe vera gel alleviates cardiotoxicity in streptozocin-induced diabetes in rats.

Neeti Jain1, Rajagopalan Vijayaraghavan, Satish Chandra Pant, Vinay Lomash, Mohammed Ali.   

Abstract

OBJECTIVES: Persistent hyperglycaemia results in oxidative stress along with the generation of oxygen free radicals and appears to be an important factor in the production of secondary complications in diabetes. The aim of this work was to evaluate markers of oxidative stress in heart tissue along with the protective, antioxidant and antidiabetic activity of 30%Aloe vera gel in diabetic rats.
METHODS: Streptozocin was given as a single intravenous injection and 30%Aloe vera gel was given in two doses for 20 days, orally. Blood glucose, glycosylated haemoglobin, blood reduced glutathione, serum lactate dehydrogenase and serum creatine kinase levels were measured on day 21 after drug treatment. Heart rate and mean blood pressure were recorded at the end of the study. Different biochemical variables were evaluated in the heart tissue, including thiobarbituric acid reactive substance (TBARS), reduced glutathione, superoxide dismutase and catalase in diabetic and in Aloe vera-treated diabetic rats. KEY
FINDINGS: In streptozocin diabetic rats, the TBARS level was increased significantly, superoxide dismutase and reduced glutathione significantly decreased, and the catalase level was significantly increased. Aloe vera 30% gel (200 mg/kg) treatment in diabetic rats reduced the increased TBARS and maintained the superoxide dismutase and catalase activity up to the normal level. Aloe vera gel increased reduced glutathione by four times in diabetic rats.
CONCLUSIONS: Aloe vera gel at 200 mg/kg had significant antidiabetic and cardioprotective activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723007     DOI: 10.1211/jpp.62.01.0013

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

Review 1.  An Overview on Indications and Chemical Composition of Aromatic Waters (Hydrosols) as Functional Beverages in Persian Nutrition Culture and Folk Medicine for Hyperlipidemia and Cardiovascular Conditions.

Authors:  Azadeh Hamedi; Seyed Mahmoud Moheimani; Amirhossein Sakhteman; Hamed Etemadfard; Mahmoodreza Moein
Journal:  J Evid Based Complementary Altern Med       Date:  2017-02-09

2.  Protective effect of salidroside from Rhodiolae Radix on diabetes-induced oxidative stress in mice.

Authors:  Fenglin Li; Hong Tang; Furen Xiao; Jingli Gong; Yong Peng; Xiangle Meng
Journal:  Molecules       Date:  2011-12-01       Impact factor: 4.411

Review 3.  Aloe Genus Plants: From Farm to Food Applications and Phytopharmacotherapy.

Authors:  Bahare Salehi; Sevil Albayrak; Hubert Antolak; Dorota Kręgiel; Ewelina Pawlikowska; Mehdi Sharifi-Rad; Yadav Uprety; Patrick Valere Tsouh Fokou; Zubaida Yousef; Zainul Amiruddin Zakaria; Elena Maria Varoni; Farukh Sharopov; Natália Martins; Marcello Iriti; Javad Sharifi-Rad
Journal:  Int J Mol Sci       Date:  2018-09-19       Impact factor: 5.923

Review 4.  Aloe vera and Streptozotocin-Induced Diabetes Mellitus.

Authors:  Fatemeh Haghani; Mohammad-Reza Arabnezhad; Salman Mohammadi; Ali Ghaffarian-Bahraman
Journal:  Rev Bras Farmacogn       Date:  2022-03-10       Impact factor: 2.464

Review 5.  Evaluation of biological properties and clinical effectiveness of Aloe vera: A systematic review.

Authors:  Maharjan H Radha; Nampoothiri P Laxmipriya
Journal:  J Tradit Complement Med       Date:  2014-12-23

6.  Herbal therapy: A review of emerging pharmacological tools in the management of diabetes mellitus in Africa.

Authors:  Cromwell Mwiti Kibiti; Anthony Jide Afolayan
Journal:  Pharmacogn Mag       Date:  2015-10       Impact factor: 1.085

7.  Blood glucose lowering activity of aloe based composition, UP780, in alloxan induced insulin dependent mouse diabetes model.

Authors:  Mesfin Yimam; Jifu Zhao; Brandon Corneliusen; Mandee Pantier; Lidia Brownell; Qi Jia
Journal:  Diabetol Metab Syndr       Date:  2014-05-24       Impact factor: 3.320

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.